Arbutus Biopharma | Investor Presentation Deck | 28 slides · page 10 of 28
The slide outlines the study structure for a clinical trial, categorizing cohorts by dosage and patient status (HBV DNA +/-).
Pitch deck · appendix_methodology · present_framework · balanced density
Slide locked Sign in to view
Slide schematic 5/5
diagram 1/1 disclaimer 1/1 list 1/1 paragraph 1/1 title 1/1
Components 5
process disclaimer bullet paragraph headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.